₹536.95
₹-8.70 (-1.59%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,273 Cr
P/E
—
ROE
23.02%
ROCE
20.14%
About Q-Line Biotech Ltd
Q-Line Biotech are engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
Founded
2010
CEO
Saurabh Garg
Employees
0
HQ
Lucknow, Uttar Pradesh
About Q-Line Biotech Ltd
Q-Line Biotech are engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
Founded:2010
CEO:Saurabh Garg
Employees:0
HQ:Lucknow, Uttar Pradesh
Finished Products
No finished products reported
This company hasn’t disclosed any finished products breakdown.
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹600
52W Low
₹431
Volume43.20K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
N/A
Valuation
P/B Ratio
5.21x
Valuation
EPS
₹0.00
Valuation
Dividend Yield
0.00%
Valuation
ROE
23.02%
Profitability
ROCE
20.14%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.86x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
19.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.